Maraviroc Waymade (Maraviroc)

Maraviroc blocks the CCR5 co‑receptor on CD4+ T‑cells, preventing the HIV‑1 envelope protein gp120 from binding. This inhibition stops the virus from entering the cell, reducing the number of infected cells and lowering overall viral load when combined with other antiretrovirals.

The dosage of Maraviroc Waymade is determined by the prescribing clinician based on the patient’s clinical status, viral load, and other medications. The prescriber will select the appropriate strength and dosing schedule according to current treatment guidelines.

Safety data for Maraviroc in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made together with a qualified healthcare professional.

To order Maraviroc Waymade, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Maraviroc belongs to the CCR5 antagonist class, which differs from protease inhibitors, nucleoside reverse transcriptase inhibitors, and integrase inhibitors. Its unique mechanism targets the entry step of CCR5‑tropic HIV, making it a valuable option for patients with resistance to other drug classes or when a specific entry‑inhibitor strategy is desired.

Maraviroc Waymade should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture. Keep the product away from direct sunlight and do not store in a refrigerator or freezer unless otherwise specified by the manufacturer.

Maraviroc Waymade is administered orally, typically as a tablet taken with or without food, according to the prescriber’s instructions. The exact dosing schedule, including frequency and duration, is individualized based on the patient’s treatment plan.

Serious risks include hepatotoxicity, severe allergic reactions such as anaphylaxis, psychiatric effects like depression or suicidal thoughts, QT interval prolongation that can lead to cardiac arrhythmias, and rare but severe skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored regularly for these events.

Maraviroc Waymade should not be used by individuals with known hypersensitivity to Maraviroc or any of its excipients. It is also contraindicated in patients with severe liver impairment or those taking contraindicated strong CYP3A4 inducers without appropriate dose adjustment.